102
Views
3
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease

Progress of tissue injury in appendicitis involves the serine proteases uPA and PAI-1

, MD, , , , &
Pages 579-584 | Received 21 Oct 2008, Published online: 08 Jul 2009

References

  • Carr NJ. The pathology of acute appendicitis. Ann Diagn Pathol 2000; 4: 46
  • Humes DJ, Simpson J. Acute appendicitis. Br Med J 2006; 333: 530
  • Marudanayagam R, Williams GT, Rees BI. Review of the pathological results of 2660 appendicectomy specimens. J Gastroenterol 2006; 41: 745
  • Pieper R, Kager L, Tidefeldt U. Obstruction of appendix vermiformis causing acute appendicitis. An experimental study in the rabbit. Acta Chir Scand 1982; 148: 63
  • Arnbjornsson E, Bengmark S. Obstruction of the appendix lumen in relation to pathogenesis of acute appendicitis. Acta Chir Scand 1983; 149: 789
  • Ebram-Neto J, Celano RM, Lanzoni VF, Juliano Y, Novo NF, Canduro AB, et al. Acute appendicitis. Experimental model in rabbits. Arq Gastroenterol 2000; 37: 114
  • Arnbjornsson E, Bengmark S. Role of obstruction in the pathogenesis of acute appendicitis. Am J Surg 1984; 147: 390
  • Korner, H, Sondenaa, K, Soreide, JA, Andersen, E, Nystad, A, Lende the, , et al. Incidence of acute nonperforated and perforated appendicitis: age-specific and sex-specific analysis. World J Surg 1997;21:313.
  • Korner H, Sondenaa K, Soreide JA. Perforated and non-perforated acute appendicitis: one disease or two entities?. Eur J Surg 2001; 167: 525
  • Luckmann R. Incidence and case fatality rates for acute appendicitis in California. A population-based study of the effects of age. Am J Epidemiol 1989; 129: 905
  • Andersson R, Hugander A, Thulin A, Nyström PO, Olaison G. Indications for operation in suspected appendicitis and incidence of perforation. Br Med J 1994; 308: 107
  • Kraemer M, Kremer K, Leppert R, Yang Q, Ohman C, Fuchs KH. Perforating appendicitis: is it a separate disease? The Acute Abdominal Pain Study Group. Eur J Surg 1999; 165: 473
  • Livingston EH, Woodward WA, Sarosi GA, Haley RW. Disconnect between incidence of nonperforated and perforated appendicitis: implications for pathophysiology and management. Ann Surg 2007; 245: 886
  • Solberg A, Holmdahl L, Falk P, Palmgren I, Ivarsson M.-L. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. Int J Colorectal Dis 2008; 23: 611
  • Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 254
  • Grondahl-Hansen J, Kirkeby LT, Ralfkiaer E, Kristensen P, Lund LR, Dano K. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol 1989; 135: 631
  • Whawell SA, Wang Y, Fleming KA, Thompson EM, Thompson JN. Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J Pathol 1993; 169: 67
  • Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995; 161: 315
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265
  • Soreide K. Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia. Scand J Gastroenterol 2008; 43: 902
  • Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007; 97: 336
  • Schmitt M, Wilhelm OG, Reuning U, Krüger A, Harbeck N, Lengyel E, et al. The urokinase plasminogen activator system as a novel target for tumour therapy. Fibrinol Proteol 2000; 14: 114
  • Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536
  • van der Poll T, Levi M, Buller HR, van Deventer SJ, deBoer JP, Hack CE, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174: 729
  • Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999; 56: 104
  • Degryse B, Sier CF, Resnati M, Conese M, Blasi F. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor. FEBS Lett 2001; 505: 249
  • Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 2004; 25: 450
  • Kwak SH, Mitra S, Bdeir K, Strassheim D, Park JS, Kim JY, et al. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J Leukocyte Biol 2005; 78: 937
  • Kwak SH, Wang XQ, He Q, Fang WF, Mitra S, Bdeir K, et al. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway. Thromb Haemost 2006; 95: 829
  • Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998; 58: 195
  • Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004; 104: 3943
  • Senno SL, Pechet L. Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature. J Thromb Thrombolysis 1999; 8: 105–12
  • Incesu L, Yazicioglu AK, Selcuk MB, Ozen N. Contrast-enhanced power Doppler US in the diagnosis of acute appendicitis. Eur J Radiol 2004; 50: 201
  • Patriquin HB, Garcier JM, Lafortune M, Yazbeck S, russo P, Jequier P, et al. Appendicitis in children and young adults: Doppler sonographic-pathologic correlation. AJR Am J Roentgenol 1996; 166: 629
  • Nunes FC, Silva AL. Acute ischaemic appendicitis in rabbits: new model with histopathological study. Acta Chir Bras 2005; 20: 399
  • de Jong E, Porte RJ, Knot EA, Verheijer JH, Dees J. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 1989; 30: 188
  • Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2008; 20: 912
  • Danese, S, Papa, A, Saibeni, S, Repiei, A, Malesci, A, Vecchi, M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2006;1.13.
  • Miseljic S, Galandiuk S, Myers SD, Wittliff JL. Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease. J Clin Lab Anal 1995; 9: 413
  • Sans M, Tassies D, Pellise M, Espinosa G, Quint? L, Piqué JM, et al. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 17: 1039
  • Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21: 127

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.